ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 733397 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 733397; 2) Community: the network communities that were significantly associated with the response to NSC 733397; 3) Molecule: the relationships between components within communities and NSC 733397; 4) MDR: the compounds that were significantly associated with the NSC 733397.

NSC Compound Enrichment Correlation
NSC 649270 Benzo[d]naphtho[1,2-b]pyran-6-one, 1-hydroxy-10-methyl-7,8,9,10-tetrahydro- 0.000100665759440623 -0.33274333
NSC 717066 Null 0.000125296947977996 0.48508859
NSC 740 Methotrexate 0.000155853121040032 0.5584652
NSC 731806 Null 0.000177788864158556 0.3407599
NSC 129757 Null 0.000184748296800008 0.0091686686
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.000184748296800008 0.44765289
NSC 701194 Null 0.000184748296800008 0.5990872
NSC 709437 Null 0.000197378553434947 0.56461559
NSC 727082 16-[3-Methoxy-4-(2-piperidin-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.000197378553434947 0.51057149
NSC 746684 7-{[3-(dibutylamino)propyl]amino}-5-imino-1,3,6-triphenyl-5,6-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dithione 0.000197378553434947 0.39773389
Total:118  Current:1    [First] [Prev] [Next] [Last]